FDA

Dear Research Advocate: The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word! One hundred and sixty five university presidents and chancellors, representing all 50 states, have called on the president and Congress to reverse the pending “innovation deficit” in an open...
Dear Research Advocate: Myth #1: Congress doesn’t pay attention during the August recess. Not true! Many town hall meetings are planned. Since the debt ceiling and appropriations negotiations are coming up in September, the August recess is actually a very important time for advocacy. Use this month to drive the point home that medical research should not be subjected to budget cuts by attending a town hall meeting, meeting with district staff and participating in our social media campaign, #curesnotcuts. Click here for sample messages, or draw from a recent op-ed penned by The Honorable John Edward Porter, Research!America chair. The op-ed ran in several McClatchy-Tribune newspapers across...
Dear Research Advocate: Myth #1: Congress doesn’t pay attention during the August recess. Not true! Many town hall meetings are planned. Since the debt ceiling and appropriations negotiations are coming up in September, the August recess is actually a very important time for advocacy. Use this month to drive the point home that medical research should not be subjected to budget cuts by attending a town hall meeting, meeting with district staff and participating in our social media campaign, #curesnotcuts. Click here for sample messages, or draw from a recent op-ed penned by The Honorable John Edward Porter, Research!America chair. The op-ed ran in several McClatchy-Tribune newspapers across...
Cyclospora cayetanensis Photo credit: CDC The Centers for Disease Control and Prevention is closely monitoring a new stomach bug that has hit several states. The one-celled parasite known as Cyclospora, which causes diarrhea, stomach cramps and other symptoms normally associated with a viral stomach bug, has sickened hundreds of people across the country. As of this week, the CDC has been notified of 285 cases of Cyclospora infection in 11 states including Iowa, Nebraska, Texas, Wisconsin, Georgia, Connecticut, New Jersey, Minnesota and Ohio. At least 18 persons reportedly have been hospitalized in three states with most of the illnesses surfacing between mid-June through early July. The...
Cyclospora cayetanensis Photo credit: CDC The Centers for Disease Control and Prevention is closely monitoring a new stomach bug that has hit several states. The one-celled parasite known as Cyclospora, which causes diarrhea, stomach cramps and other symptoms normally associated with a viral stomach bug, has sickened hundreds of people across the country. As of this week, the CDC has been notified of 285 cases of Cyclospora infection in 11 states including Iowa, Nebraska, Texas, Wisconsin, Georgia, Connecticut, New Jersey, Minnesota and Ohio. At least 18 persons reportedly have been hospitalized in three states with most of the illnesses surfacing between mid-June through early July. The...
Tell Congress to Make it Permanent. The R&D tax credit, a proven engine of economic development, was created more than 30 years ago and spurs innovation by companies of every size across every sector. For medical research and development, the tax credit not only creates jobs, but it enables critical R&D focused on a host of disabling and deadly illnesses. However, as it stands, the tax credit needs to be reauthorized by Congress and the president every year. This creates uncertainty for businesses and hinders the full economic benefit of this incentive. Strengthening the tax credit by making it permanent is vital to continuing our nation’€™s commitment to research. The Senate...
Tell Congress to Make it Permanent. The R&D tax credit, a proven engine of economic development, was created more than 30 years ago and spurs innovation by companies of every size across every sector. For medical research and development, the tax credit not only creates jobs, but it enables critical R&D focused on a host of disabling and deadly illnesses. However, as it stands, the tax credit needs to be reauthorized by Congress and the president every year. This creates uncertainty for businesses and hinders the full economic benefit of this incentive. Strengthening the tax credit by making it permanent is vital to continuing our nation’€™s commitment to research. The Senate...
Dear Research Advocate: Our elected representatives know they must make hard tax and entitlement reform decisions, and, for the sake of the nation, ensure those decisions foster economic growth and societal progress. Part of that equation is federal funding for medical research sufficient to capitalize on unprecedented scientific opportunity and tackle urgent threats like Alzheimer’€™s Disease. As I’€™ve highlighted before, a majority of Americans say they are willing to pay additional taxes ’€” $1 more per week (which amounts to approximately $4.4 billion annually) ’€” if they knew those dollars were funding medical research. The public is on our side with their wallets as well as their...
Dear Research Advocate: Our elected representatives know they must make hard tax and entitlement reform decisions, and, for the sake of the nation, ensure those decisions foster economic growth and societal progress. Part of that equation is federal funding for medical research sufficient to capitalize on unprecedented scientific opportunity and tackle urgent threats like Alzheimer’€™s Disease. As I’€™ve highlighted before, a majority of Americans say they are willing to pay additional taxes ’€” $1 more per week (which amounts to approximately $4.4 billion annually) ’€” if they knew those dollars were funding medical research. The public is on our side with their wallets as well as their...
by Mary Woolley, Research!America President and CEO. This entry was originally posted as a guest contribution to PhRMA’€™s Conversations forum. A shift in attitude among elected officials is necessary if this nation is to succeed in combating disease and stemming the rise of health care costs. Federal funding for the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and other agencies that conduct medical and health research has not kept pace with scientific opportunity, jeopardizing our ability to find cures for deadly disease and to maintain our global competitive edge. Medical research has not risen to the upper ranks of our nation’€™s priorities in the halls...

Pages

Sidebar Quote

Luck shouldn't play a role in why I'm alive.
Laurie MacCaskill, a seven-year pancreatic cancer survivor